Pfizer sells swine flu business in China; Emerging World Pharma makes generics for Ghana;

> Pfizer is selling its Chinese swine flu business to meet that country's anti-monopoly law as a condition for approval of the drug giant's merger with Wyeth. Article

> Emerging World Pharma will begin testing and manufacturing generic drugs for the Catholic Diocese of Sunyani, Ghana. Release

> Ubichem Research of Budapest has passed regulatory muster as a cGMP supplier of radio-labeled active pharmaceutical ingredients. Release

> Nutra Pharma has tapped distributor Henry Schein to handle the Nyloxin-branded pain relievers in the U.S. Release

> Ohr Pharmaceutical has received a patent for its method of synthesizing a therapeutic agent, EVIZON, used in several of its compounds, including a treatment for Wet-AMD. Announcement

Webinar

Using AI and RWD to Uncover Rare Disease Insights, Accelerate Commercialization and Improve Patient Outcomes

Wednesday, March 24 | 2pm ET / 11am PT

Learn how IPM.ai transformed real world data into real world insights to assist Audentes in their development of AT132 for the treatment of XLMTM. The session reviews how IPM.ia and Audentes collaborated to uncover the XLMTM patient population.